title: In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany.
authors.affiliation: Antiinfectives Intelligence GmbH, Campus of the University of Applied Sciences, Rheinbach, Germany Rhine University of Applied Sciences, Cologne, Germany michael.kresken@antiinfectives-intelligence.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Kresken
authors.affiliation: Antiinfectives Intelligence GmbH, Campus of the University of Applied Sciences, Rheinbach, Germany.
authors.forename: Barbara
authors.initials: B
authors.lastname: Körber-Irrgang
mesh_terms: D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009600:Nitroquinolines / Q000627:therapeutic use* / Q000652:urine; D010045:Outpatients; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000892:Anti-Infective Agents, Urinary; D009600:Nitroquinolines; D005578:Fosfomycin; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C005308:nitroxoline